The partnership with Siren Biotechnology could lead to an increase in Catalent's production volume and potentially its revenue, as it taps into the growing demand for gene therapies in cancer treatment. This collaboration highlights Catalent's capabilities and expertise in the gene therapy production space, which could attract more partnerships and enhance its reputation in the biotech industry.